Cancer Nanomedicine Consortium
Cancer Nanomedicine consortium
Concept: To start integrating scientific expertise from faculties of engineering, medicine, and life sciences within Aligarh Muslim University (AMU) to address a complex health problem – Cancer. Further, other relevant institutions will be added from within and outside India.
Genesis of the idea: The idea of forming this consortium emanates from the training, expertise and accomplishments of Dr. Mohammad Azhar Aziz, Director, Interdisciplinary Nanotechnology Center. He was part of an integrative cancer biology program initiated by the National Cancer Institute, National Institute of Health, USA. This initiative brought together Massachusetts General Hospital, Boston; Dana-Farber Cancer Institute, Boston; Lawrence Berkeley National Laboratory, Berkeley; Ohio State University, Columbus; Massachusetts Institute of Technology, Boston; University Hospital of Cleveland, Cleveland; Duke University, Durham; Stanford University School of Medicine, Stanford; Vanderbilt University Medical Center, Nashville. This program was able to integrate expertise across disciplines from several premier institutes.
With this training, he successfully established a ‘Colorectal cancer research program’ at King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, KSA.
“Cancer is an overly complex problem that cannot be addressed by tunnel vision from the scope of a single expertise”.
Director and Associate Professor